Vicarious Surgical executive sells 942 shares for taxes

Vicarious Surgical Inc. President and director Adam David Sachs reported an open-market sale of 942 shares of Class A Common Stock on February 20, 2026, at a weighted average price of $2.0878 per share.

Rhea-AI Filing Summary

Vicarious Surgical Inc. President and director Adam David Sachs reported an open-market sale of 942 shares of Class A Common Stock on February 20, 2026, at a weighted average price of $2.0878 per share. After this transaction, he held 46,943 shares directly.

The sale was executed under a mandated “sell to cover” arrangement to satisfy tax withholding obligations from vesting restricted stock units granted on May 19, 2022, and did not represent a discretionary trade by Sachs.

Insider Trade Summary

Net Seller: 942 shares

Net Sell 1 txn

Insider Sachs Adam David

Role President

Sold 942 shs ($2K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	942	$2.0878	$2K

Holdings After Transaction: Class A Common Stock — 46,943 shares (Direct)

Footnotes (2)

1. F1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
2. F2. This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Vicarious Surgical (RBOT) report?

Vicarious Surgical reported that President and director Adam David Sachs sold 942 shares of Class A Common Stock. The transaction occurred on February 20, 2026, as an open-market sale at a weighted average price of $2.0878 per share.

Why did Adam David Sachs sell Vicarious Surgical (RBOT) shares?

The sale was made to cover tax withholding obligations from vesting restricted stock units granted on May 19, 2022. It was executed under the company’s equity incentive plan and did not represent a discretionary trade by Sachs.

How many Vicarious Surgical (RBOT) shares did Adam David Sachs sell and at what price?

Adam David Sachs sold 942 shares of Vicarious Surgical Class A Common Stock at a weighted average price of $2.0878. Footnotes state individual trade prices ranged between $1.845 and $2.290 per share across multiple executions.

How many Vicarious Surgical (RBOT) shares does Adam David Sachs hold after the sale?

Following the February 20, 2026 transaction, Adam David Sachs directly held 46,943 shares of Vicarious Surgical Class A Common Stock. This figure reflects his ownership after completing the 942-share sell-to-cover transaction for tax withholding.

Was the Vicarious Surgical (RBOT) insider sale a discretionary trade?

No, the sale was not discretionary. It was mandated by Vicarious Surgical’s equity incentive plan as a “sell to cover” transaction to fund tax withholding obligations related to vesting restricted stock units granted on May 19, 2022.

What price range applied to the Vicarious Surgical (RBOT) insider share sales?

The weighted average sale price was $2.0878 per share, based on multiple trades. Footnotes explain that individual transactions occurred at prices ranging from $1.845 to $2.290 per share, with full trade details available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:59 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sachs Adam David

(Last) (First) (Middle)

C/O VICARIOUS SURGICAL INC.

78 FOURTH AVENUE

(Street)

WALTHAM MA 02451

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Vicarious Surgical Inc. [ RBOT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President

3. Date of Earliest Transaction (Month/Day/Year)
02/20/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	02/20/2026		S(1)		942	D	$2.0878(2)	46,943	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units that were granted on May 19, 2022. The sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

2. This figure is the weighted average sales price of multiple trades ranging from $1.845 to $2.290 per share. The Reporting Person undertakes to provide the staff of the Securities Exchange Commission, Vicarious Surgical Inc. or any security holder of Vicarious Surgical Inc. full information about the number of shares sold at each separate price upon request.

	/s/ Sarah Romano, Attorney-in-Fact	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.